Trial Profile
Efficacy and Safety of Etanercept Dose Reduction in Patients With Ankylosing Spondylitis
Status:
Not yet recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Etanercept (Primary)
- Indications Ankylosing spondylitis
- Focus Therapeutic Use
- 08 Jan 2016 New trial record